Home
Categories
States
Check Your Home
Home
/
Categories
/
Medications & Supplements
/
Prescription Drugs
Prescription Drugs
All
Prescription Drugs
(2121)
Over-the-Counter
(232)
Dietary Supplements
(165)
Topical Products
(406)
Veterinary Medicines
(64)
2,121 recalls
Show
24
48
96
per page
Northwind Pharmaceuticals
Medium Risk
FDA Drug
Northwind Pharmaceuticals Prescription Drugs Recalled for CGMP Deviations
Distributed nationwide
Sold at Retail Pharmacies
Recalled
Apr 26, 2023
Added
Mar 20, 2026
Medium Risk
FDA Drug
Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Recalled for Quality
Distributed nationwide
Sold at Retail pharmacies
Recalled
Oct 30, 2025
Added
Mar 20, 2026
Medium Risk
FDA Drug
Sun Pharmaceutical Amphotericin B Liposome Recalled for Potency Issues
Distributed nationwide
Sold at Hospitals, Infusion Centers +1 more
11,016 units affected
Recalled
May 8, 2024
Added
Mar 20, 2026
Sagent Pharmaceuticals
Medium Risk
FDA Drug
Nafcillin for Injection Recalled for Lack of Sterility Assurance
Distributed nationwide
Sold at Hospitals, Healthcare Facilities +2 more
4,870,160 units affected
Recalled
May 23, 2023
Added
Mar 20, 2026
Eugia US
Medium Risk
FDA Drug
Eugia Progesterone Injection USP Recalled for Glass Particulate Matter
Distributed nationwide
Sold at Wholesalers, Healthcare providers
Glass fragments contamination
Recalled
Jan 7, 2025
Added
Mar 20, 2026
Sunstar Americas
High Risk
FDA Drug
Sunstar Americas, Inc.: Paroex (Chlorhexidine Gluconate) Oral Rinse Recalled for Potential Contamination
Distributed nationwide
Sold at Pharmacies
Burkholderia cepacia complex (BCC) contamination
Recalled
Jan 11, 2021
Added
Mar 20, 2026
Medium Risk
FDA Drug
CAPS Peripheral Parenteral Nutrition Recalled for Lack of Processing Controls
Sold in California
Sold at Clinical distributors, Direct to healthcare facilities
Recalled
Jul 16, 2025
Added
Mar 20, 2026
Dr. Reddy's Laboratories
Low Risk
FDA Drug
Dr. Reddy's Glimepiride Tablets Recalled for Tablet Misprint
Distributed nationwide
Sold at Pharmacies
73,761 units affected
Recalled
Feb 6, 2024
Added
Mar 20, 2026
Exela Pharma Sciences
High Risk
FDA Drug
Sodium Bicarbonate Injection Recalled for Lack of Sterility Assurance
Distributed nationwide
Microorganisms contamination
103,950 units affected
Recalled
Mar 27, 2025
Added
Mar 20, 2026
Ascend Laboratories
Medium Risk
FDA Drug
Mycophenolic Acid Tablets Recalled for Failed Dissolution
Distributed nationwide
117,493 units affected
Recalled
Sep 24, 2024
Added
Mar 20, 2026
Amneal Pharmaceuticals
Medium Risk
FDA Drug
Amneal Pharmaceuticals, Inc.: Ranitidine Tablets and Syrup Recalled for Cancer-Causing Impurity NDMA
Distributed nationwide
Sold at Retail Pharmacies
N-nitrosodimethylamine (NDMA) contamination
Recalled
Dec 10, 2019
Added
Mar 20, 2026
Imprimis NJOF
Medium Risk
FDA Drug
Imprimis NJOF Sterile Ophthalmic Solution Recalled for Subpotency
Distributed nationwide
Recalled
Apr 29, 2024
Added
Mar 20, 2026
SOMERSET THERAPEUTICS
Low Risk
FDA Drug
Cisatracurium Besylate Injections Recalled for Subpotency
Distributed nationwide
Sold at Wholesalers, Hospitals +1 more
152,310 units affected
Recalled
Dec 15, 2025
Added
Mar 20, 2026
Zydus Pharmaceuticals (USA)
Medium Risk
FDA Drug
Zydus Icosapent Ethyl Capsules Recalled for Burnt or Melted Capsules
Sold in Illinois, Pennsylvania, Mississippi
Sold at Retail Pharmacies
A product complaint was reported for burnt or melted capsules; no injuries mentioned.
Recalled
Jun 12, 2025
Added
Mar 20, 2026
Medium Risk
FDA Drug
Leiters Health Sterile Injectable Vials Recalled for Glass Delamination
Distributed nationwide
Sold at Hospitals, Surgical Centers +2 more
Glass fragments contamination
Recalled
Feb 29, 2024
Added
Mar 20, 2026
AuroMedics Pharma
Medium Risk
FDA Drug
AuroMedics Pharma LLC: Ranitidine Tablets, Capsules, and Syrup Recalled for NDMA Contamination
Distributed nationwide
Sold at Dolgencorp LLC, Aurobindo Pharma USA, Inc. +1 more
N-nitrosodimethylamine (NDMA) contamination
Recalled
Nov 26, 2019
Added
Mar 20, 2026
Imprimis NJOF
Medium Risk
FDA Drug
Imprimis NJOF Sterile Injectable Drugs Recalled for Lack of Sterility Assurance
Distributed nationwide
Sold at Hospitals, Surgical Centers +2 more
276,840 units affected
Recalled
May 29, 2024
Added
Mar 20, 2026
Critical Risk
FDA Drug
Bleomycin for Injection Recalled for Potential Glass Particulates
Distributed nationwide
Sold at Hospira, Inc., Medical wholesalers +2 more
Glass fragments contamination
Recalled
Jan 25, 2024
Added
Mar 20, 2026
Critical Risk
FDA Drug
B. Braun Lactated Ringer's and Sodium Chloride Injections Recalled for Particles
Distributed nationwide
Sold at wholesalers, hospitals +1 more
Particulate Matter contamination
Recalled
Aug 29, 2025
Added
Mar 20, 2026
Amerisource Health Services
Medium Risk
FDA Drug
BluePoint Laboratories Duloxetine Capsules Recalled for Nitrosamine Impurity
Distributed nationwide
Sold at Pharmacies nationwide
N-nitroso-duloxetine contamination
Recalled
Dec 23, 2024
Added
Mar 20, 2026
AvKARE
Low Risk
FDA Drug
Pitavastatin Tablets Recalled for Failed Impurity and Degradation Specifications
Distributed nationwide
Impurity/Degradation contamination
10,133 units affected
Recalled
Jul 16, 2025
Added
Mar 20, 2026
Aspen Biopharma Labs Pvt.
Medium Risk
FDA Drug
Bimatoprost, Finasteride, and Other Drugs Recalled for Manufacturing Deviations
Sold in Florida
Sold at Distributors in Florida, Distributors in Hong Kong
Recalled
Mar 10, 2025
Added
Mar 20, 2026
Dr. Reddy's Laboratories
Medium Risk
FDA Drug
Dr. Reddy's Ibuprofen Tablets Recalled for Impurity Specification Failure
Distributed nationwide
Sold at Pharmacies
Unknown impurity contamination
Recalled
Aug 26, 2024
Added
Mar 20, 2026
Eugia US
Medium Risk
FDA Drug
Eugia Tirofiban Hydrochloride Injection Recalled for Failed Stability Testing
Distributed nationwide
Sold at Hospitals, Infusion Centers +1 more
Related substances/impurities contamination
Recalled
Apr 25, 2025
Added
Mar 20, 2026
Previous
1
...
81
82
83
...
89
Next
Search
Risk Level
Agency
State
Filters